• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Proton beam therapy for central nervous system tumours: outcomes from the Proton Overseas Programme

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Gaito, Simona
    Hwang, E.
    France, A.
    Whitfield, Gillian A
    Pan, Shermaine
    Price, Gareth J
    Aznar, Marianne Camille
    Crellin, A.
    Indelicato, D.
    Smith, Ed
    Affiliation
    The Christie NHS Foundation Trust, Proton Clinical Outcomes Unit, Manchester
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective In 2008, the UK National Health Service (NHS) started the Proton Overseas Programme (POP), to provide access for Proton Beam Therapy (PBT) abroad for selected tumour diagnoses, whilst two national centres were being planned. This work reports the moderate-severe toxicities and their incidence in the patient group treated for Central Nervous System (CNS) malignancies. Materials and Methods Since the start of the NHS POP Programme, an agreement between NHS England and UK referring centres ensured outcomes data collection. Follow-up correspondence has been stored in patient files in a national database and curated by the Proton Clinical Outcomes Unit, established in 2018. Clinical and treatment-related data were extracted from the central patient database. The POP patient cohort was divided into CNS and extracranial diseases. Spinal and skull base (BoS) chordoma and chondrosarcoma were grouped with CNS diseases. Grade (G) ≥3 late toxicities (LT), as per CTCAE (Common Terminology Criteria for Adverse Events) v 4.0 definition, occurring later than 90 days since completion of treatment, were recorded. Where toxicity could not be graded accurately, individualised workbooks were sent to referring centres for clarification. The follow up time is calculated from end of PBT treatment to death or last follow up. Results Between 2008 and September 2020, 830 patients were treated within the POP for CNS malignancies. Their demographics and clinical characteristics are listed in Table 1. After a median follow up of 2.65 years (range 0.03 - 11.59) the overall survival for the whole cohort was 91.33%, and the local control was 75.42%. Of note, the local control was unknown in 12.29% of the patients, and 12.29% experienced disease progression. Toxicity analysis (Table 2) was carried out on 760 patients, with patients excluded due to short follow-up (<90 days) and/or inadequate toxicity data available. Median follow up in this population is 2.8 years (0.26 - 11.59), and median radiotherapy prescription dose 54 GyRBE (34.8-79.2). In total, 69 patients (9.1%) experienced G≥3 LT, with 18 (2.4%) experiencing more than one toxicity. Of note, G≥3 LT are more common in those tumour groups (such as Chordomas and Chondrosarcomas) receiving dose-escalated treatments, and in those (such as Craniopharyngiomas and Ependymoma) commonly located in close proximity to critical organs at risk and background of multiple surgical procedures. Conclusion The results of this study indicate safety of PBT for CNS tumours, with predominantly passive scattering. Clinical outcomes from this cohort will be compared with the newest Pencil Beam Scanning technology, in the UK NHS National PBT service. Baseline toxicity assessment is essential for the correct interpretation of radiotherapy toxicities and longer follow up is needed to evaluate endpoints, such as secondary malignancies, which have a long latency period.
    Citation
    Gaito S, Hwang E, France A, Whitfield G, Pan S, Price G, et al. Proton Beam Therapy for Central Nervous System tumours: outcomes from the Proton Overseas Programme. Radiotherapy and Oncology. 2022 May;170:S771-S3. PubMed PMID: WOS:000806764200406.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/625475
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.